Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients
.
Source: OncoImmunology - Category: Cancer & Oncology Authors: Young Wha Koh Jae-Ho Han Seokjin Haam Joonho Jung Hyun Woo Lee Source Type: research